Wearable Tech Aims to Track Women's Hormones Continuously From the Wrist
A new jewelry-style wearable by Clair infers hormonal shifts in real time, challenging the once-a-year blood draw model of women's healthcare.
Summary
A startup called Clair is developing a wrist-worn wearable that continuously monitors hormonal activity in women by reading physiological signals like skin temperature, heart rate variability, and sweat response. Rather than measuring hormones directly, the device models hormonal trajectories in real time using hundreds of data inputs. The founders argue that annual or biannual hormone testing is inadequate given that hormones can fluctuate hourly, especially in perimenopausal women. The goal is to give women a fuller, more dynamic picture of their hormonal health, connecting shifts to cognition, mood, sleep, metabolism, and cardiovascular function — not just reproductive health. The technology is still emerging, but it represents a meaningful push toward continuous, personalized women's health monitoring.
Detailed Summary
Women's hormonal health has long been assessed through infrequent blood draws that capture a single moment in a constantly moving biological system. A new wearable company called Clair is challenging that approach by building a device designed to continuously infer hormone activity from the wrist, using physiological proxies rather than direct hormone measurement.
The core insight driving Clair is that hormones behave more like weather systems than static biomarkers. They shift hourly in response to stress, sleep quality, nutrition, light exposure, and age. For perimenopausal women especially, a single annual lab result may miss dramatic fluctuations that explain symptoms like brain fog, fatigue, mood instability, and poor sleep. Clair co-founder Jenny Duan describes the current standard as looking through a pinhole when the full spectrum is available.
The device works by interpreting hundreds of signals — skin conductance, temperature, heart rate variability, and sweat response — to build a real-time model of hormonal trajectories. Co-founder Abhinav Argawal likens it to an aircraft navigation system that continuously recalibrates based on live incoming data. Contextual factors like illness, alcohol, hydration, and disrupted sleep are factored into the model to reduce false readings.
Beyond reproductive health, the founders frame hormones as a biological operating system influencing cognition, cardiovascular health, metabolism, and recovery. This framing elevates continuous hormonal monitoring from a niche fertility tool to a broad healthspan instrument relevant across a woman's entire life.
Caveats are significant. The device infers rather than directly measures hormones, raising questions about accuracy and clinical validation. The article is based on a podcast episode rather than peer-reviewed research, and Clair's technology has not yet been independently validated. Health-conscious readers should watch for published clinical data before drawing firm conclusions about reliability.
Key Findings
- Hormones can fluctuate hourly, making annual blood tests an inadequate snapshot for many women.
- Clair's wearable infers hormone activity from skin conductance, temperature, HRV, and sweat — not direct measurement.
- Hormonal health influences cognition, sleep, metabolism, and cardiovascular function, not just reproduction.
- Internal Clair data suggests the menstrual cycle has up to nine sub-phases, far more than the popular four-phase model.
- Contextual inputs like stress, alcohol, and illness are integrated into the device's real-time hormonal model.
Methodology
This article is a news report summarizing a branded podcast episode featuring Clair's co-founders. It is not based on peer-reviewed research or published clinical trial data. Evidence cited is largely anecdotal and from the company's own internal dataset, which has not been independently validated.
Study Limitations
The article is promotional in nature, drawn from a podcast hosted by the same publication covering the company. No peer-reviewed studies or independent clinical validation of Clair's device are cited. Readers should treat claims about accuracy and hormonal inference as preliminary until published evidence is available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.